HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2009241445 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McCauley, John A.; Rudd, Michael T.; McIntyre, Charles J.; Liverton, Nigel J.; Gilbert, Kevin F.; Butcher, John W.

Agent Spruson & Ferguson

Pub. Number AU-A-2009241445

PCT Pub. Number WO2009/134624

Priority 61/125,688 28.04.08 US

Filing date 16 April 2009

Wipo publication date 5 November 2009

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/134624 Priority application(s): WO2009/134624

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241464-Plastic surfaces having improved surface characteristics

2009241442-Levels of BLyS/ APRIL heterotrimers in serum and use in diagnostic methods